Please tell us what you thought about today’s presentation by taking the survey below:
We have known dysfunction in certain neural circuit pathways ultimately led to symptoms in schizophrenia. These aberrant pathways caused downstream neurotransmitter dysregulation that formed the foundation of the dopamine hypothesis. Advances in imaging technology in the recent decade led to investigations into these neural circuit pathways, yielding surprising results. This webinar will feature two experts in the field of schizophrenia who will discuss how these neural pathways interact, as observed from newer imaging data. The results may warrant revision of our understanding of the dopamine hypothesis.
Chair of the Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany. Professor of Psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA.
Clinical Professor of Psychiatry, Keck USC School of Medicine; and Medical Director of Exodus Recovery, Inc. in Los Angeles, CA
Medical Science Liaison
Speakers Christoph Correll, MD and William Wirshing, MD are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Elika Hefazi, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Notifications
